Study Summary
This trial proposes a new treatment for early Alzheimer's that combines electrical stimulation with cognitive training to improve brain function & cognition.
Eligible Conditions
- Mild Cognitive Impairment
- Alzheimer's Disease
Treatment Effectiveness
Phase-Based Effectiveness
N/A
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: Change between baseline and 3 week follow-up; 3 and 6 months following study baseline
Month 6
Change in Brief Test of Adult Cognition by Telephone (BTACT)
Trial Safety
Phase-Based Safety
Trial Design
2 Treatment Groups
Active tDCS
1 of 2
Sham tDCS
1 of 2
Experimental Treatment
Non-Treatment Group
50 Total Participants · 2 Treatment Groups
Primary Treatment: Active Transcranial Direct Current Stimulation (tDCS) · Has Placebo Group · N/A
Active tDCS
Device
Experimental Group · 1 Intervention: Active Transcranial Direct Current Stimulation (tDCS) · Intervention Types: DeviceSham tDCS
Device
ShamComparator Group · 1 Intervention: Sham Transcranial Direct Current Stimulation (tDCS) · Intervention Types: DeviceTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Active Transcranial Direct Current Stimulation (tDCS)
2020
N/A
~160
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change between baseline and 3 week follow-up; 3 and 6 months following study baseline
Who is running the clinical trial?
Minneapolis Veterans Affairs Medical CenterLead Sponsor
68 Previous Clinical Trials
16,854 Total Patients Enrolled
John R McCarten, MDPrincipal InvestigatorMinneapolis Veterans Affairs Medical Center
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: